REGENXBIO Inc. (NASDAQ:RGNX) Q2 2024 Earnings Call Transcript
Operator: Welcome everyone to the Q2 2024 REGENXBIO's Earnings Conference Call. All lines have been placed on mute to prevent background noise.
Regenxbio Inc. (RGNX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Redmile Group Jeremy Green | 4,569,802 | $53,466,683 | +1% | 3.23% |
| 2. | Avidity Partners Management David Witzke And Michael Gregory | 1,300,064 | $15,210,749 | 0.64% | |
| 3. | Integral Health Asset Management Bhagwan Jay Rao | 950,000 | $11,115,000 | +25% | 1.05% |
| 4. | Aquilo Capital Management Marc Schneidman | 906,248 | $10,603,102 | 10.22% | |
| 5. | Balyasny Asset Management Dmitry Balyasny | 806,715 | $9,438,566 | +89% | 0.01% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $22.00 | 49,000 | Large Shareholder, Other | 49,000 | 2015-09-22 | Filing | |
| $22.00 | 38,500 | Large Shareholder, Other | 38,500 | 2015-09-22 | Filing | |
| $22.00 | 87,500 | Large Shareholder, Other | 1,256,542 | 2015-09-22 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $10.11 | 10,000 | 11,286 | 2024-10-01 | Filing | ||
| $12.34 | 700 | 11,286 | 2024-09-03 | Filing | ||
| $11.50 | 9,300 | 11,986 | 2024-09-03 | Filing | ||
| $15.00 | 100 | 11,286 | 2024-08-01 | Filing | ||
| $14.59 | 400 | 11,386 | 2024-08-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 8,207,548 | $147,325,487 | 0% | |
| 2. | 4,440,838 | $79,713,043 | 0% | |
| 3. | 3,939,549 | $70,714,905 | 0% | |
| 4. | 2,631,220 | $47,230,399 | 0% | |
| 5. | 1,820,382 | $32,675,865 | 0% |
News See All
Top 10 Small-Cap Stocks with Highest Upside Potential
Most giant companies start as small-cap, but by continuously developing and growing their earnings, their share price increases making them large or mega-cap companies, and along the way smart investors...
REGENXBIO Inc. (NASDAQ:RGNX) Q1 2024 Earnings Call Transcript
Operator: Good day and thank you for standing by. Welcome to REGENXBIO's First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2023 Earnings Call Transcript
REGENXBIO Inc. misses on earnings expectations. Reported EPS is $-1.43 EPS, expectations were $-1.27. REGENXBIO Inc.
REGENXBIO Inc. (NASDAQ:RGNX) Q3 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to REGENXBIO's Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.
REGENXBIO Inc. (NASDAQ:RGNX) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Q2 2023 REGENXBIO Earnings Conference Call. At this time, all participants are in a listen-only mode.
REGENXBIO Inc. (NASDAQ:RGNX) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the REGENXBIO Inc. First Quarter 2023 Conference Call. Please be advised that today's conference is being recorded.
REGENXBIO Inc. (NASDAQ:RGNX) Q4 2022 Earnings Call Transcript
Operator: Hello, and thank you for standing by. Welcome to the Q4 and Full Year 2022 REGENXBIO Earnings Call. At this time, all participants are in a listen-only mode.
11 Cheap Healthcare Stocks To Invest In
Healthcare is one of the biggest sectors in the world. According to a research report, the healthcare consumer market size was $332.391 billion and is expected to reach $667.37 billion by 2028.
Top 5 Stock Picks of Lawrence Kam's Sonic Capital
In this article, we will take a look at the top 5 stock picks of Lawrence Kam's Sonic Capital.
Billionaire Hedge Funds
